Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

100%

4 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
4(100.0%)
4Total
Phase 3(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT02500875Phase 3Unknown

Treatment of Infected Surgical Wounds With Negative Pressure Topical Therapy and Instillation (With or Without Antiseptic) Versus no Instillation

Role: lead

NCT01333670Phase 3Completed

Efficacy of Prontosan Solution on Chronic Ulcers

Role: lead

NCT01499264Phase 3Unknown

Efficacy of MySkin Patch for the Healing of Burn Wounds: a Randomised Controlled Trial

Role: lead

NCT01573234Phase 3Completed

Efficacy of MySkin Patch for the Healing of Cut Injuries and Abrasions

Role: lead

All 4 trials loaded